cadmium telluride has been researched along with Myelodysplastic Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Chen, D; Guo, D; Wang, L; Xu, P; Zhu, Y; Zuo, Y | 1 |
1 other study(ies) available for cadmium telluride and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Cadmium Compounds; Caspase 3; Daunorubicin; Drug Delivery Systems; Humans; Interleukin-3 Receptor alpha Subunit; Mice, Inbred BALB C; Mice, Nude; Myelodysplastic Syndromes; Quantum Dots; Tellurium; Toxicity Tests; Xenograft Model Antitumor Assays | 2020 |